HIV Medicine Association

On #IDPharmacistsDay, HIVMA celebrates pharmacists like Board member Sheila Montalvo, PharmD, whose expertise is vital in ensuring patients can access and maintain effective HIV treatment and prevention medications, including new long-acting options.

Missed last week's Advocacy Day? Join IDSA’s and HIVMA’s Member Advocacy Program (MAP)! Advocate with your colleagues on issues that impact the ID and HIV landscape and develop relationships with key stakeholders on the Hill. Learn more: bit.ly/3Z44hHR

Last month, Amesika Nyaku, MD, and Hanan Abdulahi, MPP, presented at the NMAC Biomedical HIV Prevention Summit, highlighting the importance of syndemic care education. Learn more about syndemic care resources: bit.ly/4v0YdwD

Today marks National Asian & Pacific Islander HIV/AIDS Awareness Day, a time to raise awareness of the impact of HIV, risk, and stigma surrounding HIV in the Asian Pacific Islander (API) community. Learn more this #NAPIHAAD: bit.ly/4dzJykO

This #HIVVaccineAwarenessDay, explore AVAC’s roadmap for advancing HIV vaccine research and development, highlighting gaps such as the need for a shared target product profile, stronger coordination, and sustained political support to accelerate progress. avac.org/pra2025-preven…

Thank you, Senator @ossoff, for taking the time to hear from our immediate past chair @colleenfkelley about the importance of fully funding federal HIV programs to end the HIV epidemic in the U.S. We appreciate your thoughtful response and commitment to this work.

Thank you to the office of @SenWarren for meeting with our members, Dr. Philip Bolduc, Dr.Andrea Ciaranello and HIV nurse Mary Piecewicz, about the importance of sustained federal funding for HIV programs.

A beautiful day for advocating for HIV funding!

Thank you @RepGregStanton for your and your staff’s strong support of funding for federal HIV programs including the Ryan White Program and HIV prevention at the CDC. #SaveHIVFunding

HIMVA board members Alice Thornton, MD and Nada Fadul, MD, FIDSA, and past chair Judith Feinberg, MD, FIDSA, are on Capitol Hill, advocating on the importance of HIV funding.

It’s Hill Day! Thank you @SenMarkKelly for meeting with us and Dr. Sudha Nagalingam today to discuss how Ryan White Program cuts in Arizona are impacting people with HIV, the benefits of HIV research to new cancer treatments and more.

In preparation for tomorrow’s HIVMA Advocacy Day, join your colleagues and take action from home by contacting Congress to urge them to support funding for federal HIV programs: bit.ly/4uc0tRM

The April 2026 ADAP Watch highlights growing fiscal pressures on AIDS Drug Assistance Programs as rising drug and insurance costs put HIV care and treatment access at risk. Read more: bit.ly/4u0rgjB

During #NationalNursesWeek, we recognize the vital role nurses play in HIV care. HIVMA is proud to honor board member Nicholas Allen, DNP, for his leadership in the field of HIV. Thank you to nurses for the expertise, dedication and care you bring to HIV patients every day.

#IDWeek2026 registration is NOW OPEN for all partner society members! Join us in person in Washington, DC, Oct. 21–24, or attend virtually from anywhere in the world. 🌍 Register today and save: idweek.org/registration

With 20+ states implementing or considering cuts to their AlDS Drug Assistance Programs due to fiscal constraints, now is the time to connect with your state's ADAP staff. Learn five questions advocates should be asking about their ADAP's fiscal outlook: savehivfunding.org/5-questions-ad…

A new data brief found that 68% of respondents reported operational changes in HIV clinics from early Nov. to early Dec. 2025, with top impacts in gender-affirming care, case management/navigation, and housing-related supports. Read the brief: bit.ly/4tTU7WA

Thank you @RepDianaDeGette for speaking up at last week’s FY27 HHS budget hearing and highlighting the real-world consequences of HIV funding instability. Protecting access to HIV prevention and care saves lives, and setbacks put progress at risk.

Is your state considering restrictions on HIV drugs? HIVMA’s policy brief offers key recommendations for state policymakers to reform prior authorization requirements, improve access to HIV medications and reduce health care costs. Read the brief: bit.ly/4k3uO0n

A fair price for Biktarvy is vital to ensure Medicare beneficiaries can access effective HIV treatment and help end the HIV epidemic, said HIVMA board member @JncherabieMD at yesterday's CMS Medicare Drug Pricing Program townhall. Dr. Cherabie's comments: bit.ly/48LRL3O